Corient Private Wealth LLC increased its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 40.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 54,511 shares of the exchange traded fund’s stock after buying an additional 15,808 shares during the quarter. Corient Private Wealth LLC owned about 0.08% of SPDR S&P Biotech ETF worth $6,646,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $27,000. Intesa Sanpaolo Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $30,000. SHP Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $31,000. Legacy Wealth Managment LLC ID acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $32,000. Finally, Smartleaf Asset Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $32,000.
SPDR S&P Biotech ETF Stock Performance
Shares of XBI opened at $151.59 on Friday. The stock has a 50 day moving average price of $134.86 and a 200 day moving average price of $128.51. SPDR S&P Biotech ETF has a one year low of $82.04 and a one year high of $154.70. The stock has a market capitalization of $9.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
